The Delhi High Court quashed the reassessment proceedings against Teva USA, holding that an Indian payer’s location alone does not establish accrual of income in India. It also set aside the AAR’s order and directed a refund of approximately ₹783 crore in TDS to Teva Israel, subject to corporate guarantees and applicable interest.
Back
